US › Healthcare

Anbio Biotechnology Class A Ordinary Shares (NNNN)

US · Healthcare · Medical Instruments & Supplies

$3.13-5.15%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$4.7M

Revenue YoY

-25.1%

Net profit

$3.0M

Profit YoY

-21.8%

Net margin

64.1%

Key statistics

Market cap

$204.5M

P/E

31.1

Forward P/E

0.0

P/B

8.89

Book value

$0.69

EPS (TTM)

$0.15

52-week high

$44.73

52-week low

$4.16

50-day MA

$7.21

200-day MA

$19.60

Shareholding

Insiders

4.78%

Institutions

5.01%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.06%
Bank of America Corp	0.03%
BNP Paribas Arbitrage, SA	0.03%
Marshall Wace Asset Management Ltd	0.03%
Morgan Stanley - Brokerage Accounts	0.02%
UBS Group AG	0.00%
EverSource Wealth Advisors, LLC	0.00%
Advisor Group Holdings, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anbio Biotechnology Class A Ordinary Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.